Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J0517 |
Short Description | Inj., benralizumab, 1 mg |
Long Description | Injection, benralizumab, 1 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2019-01-01 |
Date Added | 2019-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
00310173030 | J0517 | Inj., benralizumab, 1 mg | Fasenra | ASTRAZENECA | 1 MG | 1 | 1 | 30 | 30 |
00310183030 | J0517 | Inj., benralizumab, 1 mg | Fasenra | ASTRAZENECA | 1 MG | 1 | 1 | 30 | 30 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 1 MG |
HCPCS/CPT Billing Units | 1 |
Total doses ordered | |
Billing Units | 1 |
Drug Details
-
Benralizumab injection is used along with other medications to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in adults and children 12 years and older whose asthma is not controlled with their current asthma medication. Benralizumab injection is in a class of medications called monoclonal antibodies. It works by reducing a certain type of white blood cell to help decrease swelling and irritation of the airways to allow for easier breathing.